Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | NEU2 | Q9Y3R4 | 3/20 | 0.44 |
| ▸ | NEU4 | Q8WWR8 | 2/20 | 0.44 |
| ▸ | NEU3 | Q9UQ49 | 2/20 | 0.44 |
| ▸ | NEU1 | Q99519 | 1/20 | 0.44 |
| ▸ | SIGLEC7 | Q9Y286 | 1/20 | 0.42 |
| ▸ | MAG | P20916 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30377089 | 1.00 | NANP (0.56) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL10339608 | 0.95 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL8377625 | 0.92 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL21778926 | 0.91 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL21162637 | 0.91 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL24630166 | 0.91 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL21138938 | 0.91 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL12391270 | 0.91 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL19316071 | 0.91 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 | |
| SCHEMBL15253008 | 0.91 | NANP (0.58) | NANPL3MBTL1NEU2NEU4NEU3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250258166-A1 | MEANS AND METHODS FOR HIGH-THROUGHPUT GLYCOPROFILING OF PROTEINS | GLYCANOSTICS S.R.O. (SK) | 2025-08-14 | — | — | US | disclosed |
| WO-2025058046-A1 | METHOD FOR PRODUCING GLYCOPEPTIDE-CONTAINING COMPOSITION | 雪印メグミルク株式会社 | 2025-03-20 | — | — | WO | disclosed |
| EP-4508429-A1 | MEANS AND METHODS FOR HIGH-THROUGHPUT GLYCOPROFILING OF PROTEINS | Glycanostics s.r.o. (SK) | 2025-02-19 | — | — | EP | disclosed |
| US-20240361330-A1 | STANDARD FOR GLYCOPROFILING OF PROTEINS | GLYCANOSTICS S.R.O. (SK) | 2024-10-31 | — | — | US | disclosed |
| CN-117881962-A | Standard for protein glycoprofile characterization | GLYCANOSTICS 公司 | 2024-04-12 | — | — | CN | disclosed |
| WO-2023198337-A1 | MEANS AND METHODS FOR HIGH-THROUGHPUT GLYCOPROFILING OF PROTEINS | GLYCANOSTICS S.R.O. (SK) | 2023-10-19 | — | — | WO | disclosed |
| EP-4253958-A2 | MEANS AND METHODS FOR GLYCOPROFILING OF A PROTEIN | Glycanostics s.r.o. (SK) | 2023-10-04 | — | — | EP | disclosed |
| EP-3775909-B1 | MEANS AND METHODS FOR GLYCOPROFILING OF A PROTEIN | GLYCANOSTICS S R O (SK) | 2023-05-10 | — | — | EP | disclosed |
| US-20210048437-A1 | MEANS AND METHODS FOR GLYCOPROFILING OF A PROTEIN | GLYCANOSTICS, S.R.O. (SK) | 2021-02-18 | — | — | US | disclosed |
| EP-3775909-A1 | MEANS AND METHODS FOR GLYCOPROFILING OF A PROTEIN | Glycanostics s.r.o. (SK) | 2021-02-17 | — | — | EP | disclosed |
| EP-3677127-A1 | INTESTINAL ENVIRONMENT IMPROVEMENT COMPOSITION AND METHOD FOR MANUFACTURING SAME | Megmilk Snow Brand Co. Ltd. (JP) | 2020-07-08 | — | — | EP | disclosed |
| WO-2019185515-A1 | MEANS AND METHODS FOR GLYCOPROFILING OF A PROTEIN | GLYCANOSTICS S.R.O. (SK) | 2019-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240361330-A1 | STANDARD FOR GLYCOPROFILING OF PROTEINS | GALNT14, LGALS3BP, GALNT13 | NANP 146/4885L3MBTL1 1674/4885NEU2 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.